Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Etoposide; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jan 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov, last updated 16 Jan 2009.
- 16 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Mar 2009 as reported by ClinicalTrials.gov.